APA (7th ed.) Citation

Badau, L. M., Oprean, C. M., Ciocoiu, A. D., Epure, P., & Vlaicu, B. (2026). The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2− Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review. Cancers, 18(1), 81. https://doi.org/10.3390/cancers18010081

Chicago Style (17th ed.) Citation

Badau, Larisa Maria, Cristina Marinela Oprean, Andrei Dorin Ciocoiu, Paul Epure, and Brigitha Vlaicu. "The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2− Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review." Cancers 18, no. 1 (2026): 81. https://doi.org/10.3390/cancers18010081.

MLA (9th ed.) Citation

Badau, Larisa Maria, et al. "The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2− Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review." Cancers, vol. 18, no. 1, 2026, p. 81, https://doi.org/10.3390/cancers18010081.